SEC Filings | 4D pharma plc

Filing date	Form	Description	View
17 Mar 2021	425	Filing of certain prospectuses and communications in connection with business combination transactions	View HTML 0001104659-21-037735.pdf 0001104659-21-037735.rtf 0001104659-21-037735.xls
21 Dec 2020	425	Filing of certain prospectuses and communications in connection with business combination transactions	View HTML 0001104659-20-137635.pdf 0001104659-20-137635.rtf
03 Feb 2021	425	Filing of certain prospectuses and communications in connection with business combination transactions	View HTML 0001104659-21-011189.pdf 0001104659-21-011189.rtf
08 Feb 2021	425	Filing of certain prospectuses and communications in connection with business combination transactions	View HTML 0001104659-21-013310.pdf 0001104659-21-013310.rtf
18 Mar 2021	425	Filing of certain prospectuses and communications in connection with business combination transactions	View HTML 0001104659-21-038284.pdf 0001104659-21-038284.rtf
22 Mar 2021	6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	View HTML 0001104659-21-039632.pdf 0001104659-21-039632.rtf 0001104659-21-039632.xls
01 Apr 2021	6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	View HTML 0001493152-21-007637.pdf 0001493152-21-007637.rtf 0001493152-21-007637.xls
19 Apr 2021	6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	View HTML 0001493152-21-009056.pdf 0001493152-21-009056.rtf 0001493152-21-009056.xls
19 Apr 2021	6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	View HTML 0001493152-21-009055.pdf 0001493152-21-009055.rtf 0001493152-21-009055.xls
25 May 2021	6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	View HTML 0001493152-21-012824.pdf 0001493152-21-012824.rtf 0001493152-21-012824.xls

Data provided by Kaleidoscope.